351 related articles for article (PubMed ID: 6861140)
21. Murine splenocyte migration inhibition assay I. Detection of differential responses to murine leukemia P388 and its adriamycin-resistant subline P388/ADR.
Nori M; Gothoskar BP
Neoplasma; 1983; 30(3):287-93. PubMed ID: 6223231
[TBL] [Abstract][Full Text] [Related]
22. In vivo characteristics of resistance and cross-resistance of an adriamycin-resistant subline of P388 leukemia.
Johnson RK; Chitnis MP; Embrey WM; Gregory EB
Cancer Treat Rep; 1978 Oct; 62(10):1535-47. PubMed ID: 709555
[TBL] [Abstract][Full Text] [Related]
23. Flow cytometric monitoring of cellular anthracycline accumulation in murine leukemic cells.
Krishan A; Sauerteig A; Gordon K; Swinkin C
Cancer Res; 1986 Apr; 46(4 Pt 1):1768-73. PubMed ID: 3948163
[TBL] [Abstract][Full Text] [Related]
24. Sensitivity to anthracyclines in P388/dx leukaemia cells.
Bossa R; Dasdia T; Galatulas I; Zunino F
Anticancer Res; 1986; 6(5):1037-9. PubMed ID: 3099628
[TBL] [Abstract][Full Text] [Related]
25. Effect of amphotericin B on Adriamycin transport in P388 cells.
Krishan A; Sauerteig A; Gordon K
Cancer Res; 1985 Sep; 45(9):4097-102. PubMed ID: 4028003
[TBL] [Abstract][Full Text] [Related]
26. Tyrosine and phenylalanine restriction sensitizes adriamycin-resistant P388 leukemia cells to adriamycin.
Elstad CA; Thrall BD; Raha G; Meadows GG
Nutr Cancer; 1996; 25(1):47-60. PubMed ID: 8837861
[TBL] [Abstract][Full Text] [Related]
27. Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by tamoxifen and other triparanol analogues.
Ramu A; Glaubiger D; Fuks Z
Cancer Res; 1984 Oct; 44(10):4392-5. PubMed ID: 6467200
[TBL] [Abstract][Full Text] [Related]
28. Differential agglutination of P388 adriamycin-sensitive and P388 adriamycin-resistant leukemia cells.
Basrur VS; Chitnis MP; Menon RS
Oncology; 1983; 40(3):202-4. PubMed ID: 6843944
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of quinidine effect on the antitumor activity of adriamycin and mitoxantrone in adriamycin-sensitive and -resistant P388 leukemia cells.
Parekh H; Chitnis M
Sel Cancer Ther; 1990; 6(2):93-102. PubMed ID: 2367755
[TBL] [Abstract][Full Text] [Related]
30. Enhancement of adriamycin-induced cytotoxicity by increasing retention and inhibition of DNA repair in DOX-resistant P388 cell lines with new calcium channel blocker, DMDP.
Bankusli I; Yin MB; Mazzoni A; Abdellah AJ; Rustum YM
Anticancer Res; 1989; 9(3):567-74. PubMed ID: 2764503
[TBL] [Abstract][Full Text] [Related]
31. Comparative cytotoxicities of various morpholinyl anthracyclines.
Streeter DG; Taylor DL; Acton EM; Peters JH
Cancer Chemother Pharmacol; 1985; 14(2):160-4. PubMed ID: 3971481
[TBL] [Abstract][Full Text] [Related]
32. Plasma membrane lipid structural order in doxorubicin-sensitive and -resistant P388 cells.
Ramu A; Glaubiger D; Magrath IT; Joshi A
Cancer Res; 1983 Nov; 43(11):5533-7. PubMed ID: 6311408
[TBL] [Abstract][Full Text] [Related]
33. Circumvention of vincristine and Adriamycin resistance in vitro and in vivo by calcium influx blockers.
Tsuruo T; Iida H; Nojiri M; Tsukagoshi S; Sakurai Y
Cancer Res; 1983 Jun; 43(6):2905-10. PubMed ID: 6850602
[TBL] [Abstract][Full Text] [Related]
34. Flow cytometric studies on modulation of cellular adriamycin retention by phenothiazines.
Krishan A; Sauerteig A; Wellham LL
Cancer Res; 1985 Mar; 45(3):1046-51. PubMed ID: 4038625
[TBL] [Abstract][Full Text] [Related]
35. Potentiation of pirarubicin cytotoxicity by dipyridamole in doxorubicin-resistant mouse P388 leukemia cells.
Furusawa S; Fujimura T; Kawauchi H; Sasaki K; Takayanagi Y
Res Commun Chem Pathol Pharmacol; 1991 Mar; 71(3):321-36. PubMed ID: 2047575
[TBL] [Abstract][Full Text] [Related]
36. Enhancement of doxorubicin and vinblastine sensitivity in anthracycline-resistant P388 cells.
Ramu A; Shan TC; Glaubiger D
Cancer Treat Rep; 1983 Oct; 67(10):895-9. PubMed ID: 6354437
[TBL] [Abstract][Full Text] [Related]
37. Effects of verapamil on daunomycin cellular retention and cytotoxicity in P388 leukemic cells.
Yanovich S; Preston L
Cancer Res; 1984 May; 44(5):1743-7. PubMed ID: 6713377
[TBL] [Abstract][Full Text] [Related]
38. [Reversal of acquired resistance to vinca alkaloids and anthracycline antibiotics by calcium channel blockers and calmodulin inhibitors].
Tsuruo T
Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):750-9. PubMed ID: 6585181
[TBL] [Abstract][Full Text] [Related]
39. Flow cytometric screening for selective toxicity to multidrug-resistant cells.
Frankfurt OS
J Natl Cancer Inst; 1987 Oct; 79(4):831-6. PubMed ID: 3477663
[TBL] [Abstract][Full Text] [Related]
40. Circumvention of drug resistance of P388/R cells by the combination of adriamycin and mitoxantrone with hyperthermia (42 degrees C).
Juvekar AS; Chitnis MP
Neoplasma; 1991; 38(2):207-11. PubMed ID: 2041579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
